A. McGranahan

Primary High-Grade B-Cell Lymphoma of the Breast with Concurrent IGH-BCL2 and MYC-IGL Translocations in an Adolescent Patient

L. Meltesen, R. Giller, L. Mcgavran, 2011, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

Heterogeneity of Abnormal RUNX1 Leading to Clinicopathologic Variations in Childhood B-Lymphoblastic Leukemia.

K. Swisshelm, Xiayuan Liang, Virginia M Knez, 2014, American journal of clinical pathology.

LYMPHOID NEOPLASIA Mer receptor tyrosine kinase is a therapeutic target in pre – B-cell acute lymphoblastic leukemia

Kristen M. Jacobsen, A. Tan, H. Earp, 2013 .

Keypoints

Kristen M. Jacobsen, A. Tan, H. Earp, 2019, Encyclopedia of Biometrics.

Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia

H. Earp, S. Hunsucker, H. Martinson, 2013, Oncogene.

Inhibition of MerTK increases chemosensitivity and decreases oncogenic potential in T-cell acute lymphoblastic leukemia

D. DeRyckere, D. Graham, S. Christoph, 2013, Blood Cancer Journal.

Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia

H. Earp, S. Hunsucker, H. Martinson, 2013, Oncogene.

Heterogeneity of Abnormal RUNX1 Leading to Clinicopathologic Variations in Childhood B-Lymphoblastic Leukemia.

K. Swisshelm, Xiayuan Liang, Billie J. Carstens, 2015, American journal of clinical pathology.

Gray Zone Lymphomas in Pediatric Patients

R. Giller, D. Graham, B. Greffe, 2011, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

Erratum: Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia

H. Earp, S. Hunsucker, D. DeRyckere, 2016, Oncogene.